Dilution, ATM Offerings, PIPE Deals and Reverse Splits: A Practical Guide for Small-Cap and Biotech Investors

1. What share dilution really means

Share dilution occurs when a company issues new shares or securities that can become shares. The result is straightforward: the total share count rises, and each existing share represents a smaller ownership percentage of the business.

Example: a company has 10 million shares outstanding. You own 10,000 shares, equal to 0.10% of the company. If the company issues another 5 million shares, the total share count becomes 15 million. Your 10,000 shares are unchanged, but they now represent roughly 0.067% of the company. Your economic slice is smaller.

This does not automatically mean the stock should be avoided. The better question is not “is there dilution?” but “is the company raising capital on reasonable terms, and will that capital create value per share?” In biotech, for example, a raise may be required to complete a clinical trial, reach a PDUFA date or fund a commercial launch after FDA approval.

Primary dilution and secondary offerings are not the same thing

Primary dilution happens when the company issues new shares and receives the proceeds. This is the typical case for an ATM, follow-on, registered direct, PIPE or conversion of convertible securities.

A secondary offering may involve existing insiders, sponsors, funds or large shareholders selling shares they already own. In that case the company may receive no new cash and the share count may not change, but the sudden supply can pressure the stock. It is not always “dilution” in the technical sense, but it can still be an important signal.

2. Main forms of capital raising

Public companies can raise capital in different ways. The structure they choose says a lot about management’s negotiating power and the market’s willingness to fund the company.

3. ATM offerings: the “quiet” dilution

An ATM, or At-the-Market offering, allows a company to sell newly issued shares directly into the market at prevailing prices. It is often built on a Form S-3 shelf registration and a prospectus supplement authorizing sales up to a maximum dollar amount.

The key feature is flexibility: the company does not need to sell everything at once. It can sell shares on high-volume days, after positive news or during strength in the stock. That is why ATMs are common in biotech and small-cap companies with meaningful cash burn.

Why it can be useful

If used well, an ATM can help avoid a large discounted placement. A company with important clinical data ahead may gradually strengthen its balance sheet without announcing a heavy PIPE. The market often tolerates an ATM when the company has liquidity, volume and a credible story.

Why it can be dangerous

The issue is that an ATM can become an open faucet. Every sale adds supply. If the company sells aggressively into every bounce, the stock may appear unable to move higher because each spike is being used to issue shares.

4. PIPE deals: fast capital, often expensive capital

PIPE stands for Private Investment in Public Equity. It is a private placement of common stock, preferred stock, warrants or convertible securities to a limited group of institutional or accredited investors. It is fast and useful when the company needs to close financing in days.

A PIPE is often priced at a discount to the market because investors demand compensation for risk, potential initial illiquidity, volatility and capital commitment. In weak small caps, the discount can be large and paired with warrants.

The real issue: price, warrants and resale

A PIPE should not be judged only by the amount raised. Three items matter: the share price, warrant coverage and registration rights. If investors receive deeply discounted shares plus near-free warrants, the transaction can create a heavy overhang.

Death spirals and variable-price convertibles

The most dangerous structures are those where the conversion price falls as the stock price falls. The lower the stock goes, the more shares are issued to convert the same dollar amount of debt or preferred stock. This can create a toxic loop: conversion, selling, price pressure, lower conversion price, more conversion.

5. Follow-ons and registered directs: not all raises are equal

A follow-on public offering is a public offering after an IPO. It may be primary, where the company issues new shares and receives cash, or secondary, where existing shareholders sell shares. When the price is close to market and institutional demand is strong, a follow-on can signal healthy access to capital.

A registered direct offering is faster and negotiated with selected investors, but uses securities that are registered or immediately registrable. For retail investors, it may trade like a PIPE: discount, possible warrants, selling pressure and a gap down on announcement.

6. Warrants, options and the fully diluted share count

Many investors look only at shares outstanding. That is a mistake. The real risk often sits in the fully diluted share count: common shares plus options, warrants, RSUs, convertible preferred stock, convertible debt and other instruments that can become common stock.

Warrants matter because they can hang over a stock for years. If the stock rises above the strike price, warrants can be exercised and create new shares. If the stock remains below the strike, they can still weigh on sentiment because the market knows a future supply block exists.

• Check the strike. A warrant close to the current price can become dilutive quickly.
• Check the expiration. Five-year warrants create longer overhang than short-dated warrants.
• Check anti-dilution clauses. Some warrants adjust if the company issues stock at lower prices.
• Check cashless exercise. It may allow exercise without fresh cash coming into the company.

7. Reverse splits: neutral in theory, often negative in context

A reverse split consolidates several old shares into one new share. In a 1-for-10 reverse split, 1,000 shares become 100 shares and the theoretical price is multiplied by 10. The value of the position does not change mechanically.

The problem is not the reverse split itself. The problem is why the company is doing it. In small caps, the most common reason is to regain compliance with Nasdaq or NYSE minimum price requirements, especially the $1.00 minimum bid price requirement. Nasdaq has specific rules for minimum bid-price non-compliance and compliance periods.

The most dangerous cycle: reverse split, then dilute again

Many microcaps reverse split to move the nominal price back above $1, then issue new shares through an ATM, PIPE or registered direct. The result for shareholders can be brutal: fewer shares after the split, then new dilution, then another decline, then risk of another reverse split.

8. Impact on valuation, runway and price

Dilution touches at least four areas: ownership, per-share value, runway and market perception.

Per-share value

If a company issues shares below perceived economic value, existing shareholders suffer a loss of per-share value. If it issues shares at favorable prices and deploys capital well, dilution can be offset or exceeded by value creation.

Runway

In biotech, runway is central. A company with six months of cash and a readout in twelve months is likely forced to raise. A company with twenty-four months of runway can negotiate from a stronger position. The same offering can be interpreted differently depending on whether it comes from strength or distress.

Price and sentiment

The market does not react only to the math. It reacts to the signal. A raise after positive clinical data, with high-quality institutions and a modest discount, can be absorbed well. A late-night PIPE with warrants and a deep discount before a binary catalyst can damage confidence even if it technically extends runway.

9. Red flags to check before entering

• Runway below 12 months. If the company is burning cash and has no immediate catalyst, financing risk is high.
• Large S-3 shelf and active ATM. Not automatically negative, but it gives the company immediate issuance capacity.
• Numerous warrants with low strikes. They can create overhang and future dilution.
• Variable-price convertible notes. One of the most dangerous structures for retail holders.
• Multiple reverse splits. A historical signal of difficulty preserving per-share value.
• Authorized shares far above outstanding shares. The company may have legal room to issue many new shares.
• Capital raise right before a binary catalyst. It may be prudent, but it may also signal lower internal confidence.
• Cash not rising proportionally with dilution. If shares rise dramatically while cash remains weak, capital is being consumed too quickly.

10. The Merlintrader framework for dilution risk

At Merlintrader, dilution is not read as an isolated data point. It belongs in a broader framework that includes the balance sheet, catalysts, liquidity, execution and capital-structure quality.

The final question is always: is this company using the capital markets to build value, or using shareholders as a recurring survival mechanism?

• Share-count history. Compare basic shares over the past 2–3 years with today.
• Cash and burn. Estimate how many quarters of runway remain.
• ATM and shelf. Check whether immediate issuance capacity exists.
• Fully diluted count. Add warrants, options, convertibles and preferred stock.
• Investor quality. A deal with specialized institutions is different from a deal with toxic financiers.
• Timing. A raise after strength and positive data is different from emergency financing.

11. Bottom line

Dilution should not be demonized, but it must be understood before buying. In small caps and biotech, many companies do not have sufficient revenue, burn cash and depend on the capital markets. That makes share structure a core part of the analysis, not an accounting detail.

A good investor does not look only at pipeline, headlines and catalysts. A good investor also studies shares outstanding, cash, burn, shelf capacity, ATM activity, warrants, convertibles and reverse-split history. Often the difference between a manageable trade and a dilution trap is found there.